Pfizer Inc PFE:NYSE

RT Quote | NYSE | USD

Last | 4:00 PM EDT

44.25

-0.21 (-0.47%)

Volume

12,768,594

52 week range

40.94 - 61.71

Open44.12
Day High44.37
Day Low43.68
Prev Close44.46
52 Week High61.71
52 Week High Date12/20/21
52 Week Low40.94
52 Week Low Date10/13/21

Key Stats

Market Cap248.346B
Shares Out5.612B
10 Day Average Volume19.92M
Dividend1.60
Dividend Yield3.62%
Beta0.67
YTD % Change-25.17

KEY STATS

Open44.12
Day High44.37
Day Low43.68
Prev Close44.46
52 Week High61.71
52 Week High Date12/20/21
52 Week Low40.94
52 Week Low Date10/13/21
Market Cap248.346B
Shares Out5.612B
10 Day Average Volume19.92M
Dividend1.60
Dividend Yield3.62%
Beta0.67
YTD % Change-25.17

RATIOS/PROFITABILITY

EPS (TTM)5.19
P/E (TTM)8.53
Fwd P/E (NTM)7.72
EBITDA (TTM)42.238B
ROE (TTM)37.84%
Revenue (TTM)101.132B
Gross Margin (TTM)62.21%
Net Margin (TTM)29.44%
Debt To Equity (MRQ)46.19%

EVENTS

Earnings Date11/01/2022
Ex Div Date11/03/2022
Div Amount0.40
Split Date-
Split Factor-

Latest On Pfizer Inc

How to perfectly time your new omicron-specific Covid boosterOctober 1, 2022CNBC.com
Covid vaccination linked to small increase in menstrual cycle length: NIH studySeptember 28, 2022CNBC.com
Pfizer or Moderna: Which new omicron-specific Covid booster should you get?September 27, 2022CNBC.com
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11September 26, 2022CNBC.com
Moderna asks FDA to authorize omicron Covid boosters for kids 6- to 11-year-oldsSeptember 23, 2022CNBC.com

Content From Our Affiliates

Biohaven launches as a new publicly traded companyOctober 4, 2022TipRanks
Voyager announces Pfizer exercises option to license novel capsidOctober 4, 2022TipRanks
Pfizer announces Phase 3 TALAPRO-2 trial meets primary endpointOctober 4, 2022TipRanks
Pfizer completes acquisition of Biohaven PharmaceuticalOctober 3, 2022TipRanks
Fly Intel: Top five weekend stock storiesOctober 2, 2022TipRanks

Profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Aamir Malik

Executive Vice President, Chief Business Innovation Officer

Lidia Fonseca Ph.D.

Executive Vice President, Chief Digital and Technology Officer

Douglas Lankler

Executive Vice President, General Counsel

Address

235 E 42ND ST

New York, NY

10017-5703

United States

https://www.pfizer.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
RHHBY Roche Holding AG	41.73	-0.70	-1.65%
ABBV Abbvie Inc	143.33	+1.34	+0.94%
MRK Merck & Co Inc	88.39	+0.01	+0.01%
JNJ Johnson & Johnson	165.11	-0.51	-0.31%
NVS Novartis AG	77.37	-0.86	-1.10%